Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2021-10-06 00:00:00 ET · period of report 2021-10-04 · accession 0001437749-21-023380 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-06 | 2021-10-04 | PBYI | NOUGUES MAXIMO F | CFO | S - Sale | $6.20 | -161 | 67.6K | -0.2% | -$998.20 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | S | D | 161 | $6.20 | 67,593 | D | — | — |